1.8.98.2 Adenocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24189098&form=6&db=m Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma. diagnostic usage,ongoing research,unassigned 3,4,0 1.8.98.2 Adenocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32411320&form=6&db=m Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,4 1.8.98.2 Brain Injuries http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25407820&form=6&db=m Sulfiredoxin-1 Attenuates Oxidative Stress via Nrf2/ARE Pathway and 2-Cys Prdxs After Oxygen-Glucose Deprivation in Astrocytes. causal interaction,therapeutic application,unassigned 1,2,0 1.8.98.2 Brain Ischemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25955519&form=6&db=m Sulfiredoxin-1 exerts anti-apoptotic and neuroprotective effects against oxidative stress-induced injury in rat cortical astrocytes following exposure to oxygen-glucose deprivation and hydrogen peroxide. causal interaction,therapeutic application,unassigned 3,4,0 1.8.98.2 Brain Ischemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28552673&form=6&db=m Neuroprotective effects of sulfiredoxin-1 during cerebral ischemia/reperfusion oxidative stress injury in rats. causal interaction,therapeutic application,unassigned 4,1,0 1.8.98.2 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21742584&form=6&db=m Maesopsin 4-O-beta-D-glucoside, a natural compound isolated from the leaves of Artocarpus tonkinensis, inhibits proliferation and up-regulates HMOX1, SRXN1 and BCAS3 in acute myeloid leukemia. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,1,0 1.8.98.2 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22964583&form=6&db=m Genetic polymorphisms and protein expression of NRF2 and sulfiredoxin predict survival outcomes in breast cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,4,1 1.8.98.2 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25833832&form=6&db=m Correction: Genetic Polymorphisms and Protein Expression of NRF2 and Sulfiredoxin Predict Survival Outcomes in Breast Cancer. causal interaction,diagnostic usage,therapeutic application,unassigned 2,3,1,0 1.8.98.2 Carcinogenesis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21487000&form=6&db=m Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling. therapeutic application,unassigned 1,0 1.8.98.2 Carcinogenesis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23393226&form=6&db=m Loss of sulfiredoxin renders mice resistant to azoxymethane/dextran sulfate sodium-induced colon carcinogenesis. causal interaction,ongoing research,unassigned 1,3,0 1.8.98.2 Carcinogenesis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24503444&form=6&db=m Tumor promoter-induced sulfiredoxin is required for mouse skin tumorigenesis. causal interaction,unassigned 2,0 1.8.98.2 Carcinogenesis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29906488&form=6&db=m Nrf2-activated expression of sulfiredoxin contributes to urethane-induced lung tumorigenesis. ongoing research,unassigned 1,0 1.8.98.2 Carcinogenesis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32746503&form=6&db=m SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,4 1.8.98.2 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21943684&form=6&db=m Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,2,3 1.8.98.2 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28274319&form=6&db=m [Highly expressed sulfiredoxin and ?-catenin are associated with malignancy of cervical squamous cell carcinoma]. diagnostic usage,ongoing research,therapeutic application,unassigned 4,4,1,0 1.8.98.2 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28351308&form=6&db=m Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition. causal interaction,unassigned 3,0 1.8.98.2 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32746503&form=6&db=m SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,4 1.8.98.2 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32955798&form=6&db=m Sulfiredoxin-1 is a promising novel prognostic biomarker for hepatocellular carcinoma. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,4,0 1.8.98.2 Carcinoma, Squamous Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28274319&form=6&db=m [Highly expressed sulfiredoxin and ?-catenin are associated with malignancy of cervical squamous cell carcinoma]. diagnostic usage,ongoing research,therapeutic application,unassigned 4,4,1,0 1.8.98.2 Carcinoma, Squamous Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28351308&form=6&db=m Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition. causal interaction,unassigned 3,0 1.8.98.2 Cerebral Infarction http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28552673&form=6&db=m Neuroprotective effects of sulfiredoxin-1 during cerebral ischemia/reperfusion oxidative stress injury in rats. causal interaction,therapeutic application,unassigned 4,1,0 1.8.98.2 Cerebrovascular Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27226772&form=6&db=m Genetic Polymorphisms of Transcription Factor NRF2 and of its Host Gene Sulfiredoxin (SRXN1) are Associated with Cerebrovascular Disease in a Finnish Cohort, the TAMRISK Study. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,3,0 1.8.98.2 Chronic Periodontitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30044495&form=6&db=m Comparative estimation of sulfiredoxin levels between chronic periodontitis and healthy patients - A case-control study. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,3,0 1.8.98.2 Colorectal Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26290602&form=6&db=m Sulfiredoxin Promotes Colorectal Cancer Cell Invasion and Metastasis through a Novel Mechanism of Enhancing EGFR Signaling. causal interaction,diagnostic usage,therapeutic application,unassigned 4,1,4,0 1.8.98.2 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34186206&form=6&db=m Upregulation of oxidative stress gene markers during SARS-COV-2 viral infection. therapeutic application,unassigned 1,0 1.8.98.2 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31284950&form=6&db=m Sulfiredoxin-1 alleviates high glucose-induced podocyte injury though promoting Nrf2/ARE signaling via inactivation of GSK-3?. causal interaction,unassigned 4,0 1.8.98.2 Hypersensitivity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27821734&form=6&db=m Role of sulfiredoxin as a peroxiredoxin-2 denitrosylase in human iPSC-derived dopaminergic neurons. causal interaction,ongoing research,therapeutic application,unassigned 4,1,4,0 1.8.98.2 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27226772&form=6&db=m Genetic Polymorphisms of Transcription Factor NRF2 and of its Host Gene Sulfiredoxin (SRXN1) are Associated with Cerebrovascular Disease in a Finnish Cohort, the TAMRISK Study. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,3,0 1.8.98.2 Idiopathic Pulmonary Fibrosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20718723&form=6&db=m Cell-specific elevation of NRF2 and sulfiredoxin-1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. causal interaction,diagnostic usage,unassigned 2,2,0 1.8.98.2 Infarction, Middle Cerebral Artery http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28552673&form=6&db=m Neuroprotective effects of sulfiredoxin-1 during cerebral ischemia/reperfusion oxidative stress injury in rats. causal interaction,therapeutic application,unassigned 4,1,0 1.8.98.2 Ischemic Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28552673&form=6&db=m Neuroprotective effects of sulfiredoxin-1 during cerebral ischemia/reperfusion oxidative stress injury in rats. causal interaction,therapeutic application,unassigned 4,1,0 1.8.98.2 Leukemia, Myeloid, Acute http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21742584&form=6&db=m Maesopsin 4-O-beta-D-glucoside, a natural compound isolated from the leaves of Artocarpus tonkinensis, inhibits proliferation and up-regulates HMOX1, SRXN1 and BCAS3 in acute myeloid leukemia. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,1,0 1.8.98.2 Lung Diseases, Interstitial http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20718723&form=6&db=m Cell-specific elevation of NRF2 and sulfiredoxin-1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. causal interaction,diagnostic usage,unassigned 2,2,0 1.8.98.2 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21943684&form=6&db=m Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,2,3 1.8.98.2 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22016591&form=6&db=m Nuclear factor E2-related factor 2 dependent overexpression of sulfiredoxin and peroxiredoxin III in human lung cancer. causal interaction,unassigned 2,0 1.8.98.2 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31000628&form=6&db=m The redox regulator sulfiredoxin forms a complex with thioredoxin domain-containing 5 protein in response to ER stress in lung cancer cells. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,1,1 1.8.98.2 Melanoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31248223&form=6&db=m Frugoside Induces Mitochondria-Mediated Apoptotic Cell Death through Inhibition of Sulfiredoxin Expression in Melanoma Cells. causal interaction,ongoing research,therapeutic application,unassigned 2,2,1,0 1.8.98.2 Meningoencephalitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23998805&form=6&db=m Sulfiredoxin plays peroxiredoxin-dependent and -independent roles via the HOG signaling pathway in Cryptococcus neoformans and contributes to fungal virulence. ongoing research,unassigned 2,0 1.8.98.2 Myocardial Ischemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29772252&form=6&db=m Sulfiredoxin-1 enhances cardiac progenitor cell survival against oxidative stress via the upregulation of the ERK/NRF2 signal pathway. causal interaction,therapeutic application,unassigned 4,4,0 1.8.98.2 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26290602&form=6&db=m Sulfiredoxin Promotes Colorectal Cancer Cell Invasion and Metastasis through a Novel Mechanism of Enhancing EGFR Signaling. causal interaction,diagnostic usage,therapeutic application,unassigned 4,1,4,0 1.8.98.2 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28351308&form=6&db=m Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition. causal interaction,unassigned 3,0 1.8.98.2 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28448437&form=6&db=m Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/?-Catenin Signaling Pathway. therapeutic application,unassigned 1,0 1.8.98.2 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32746503&form=6&db=m SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,4 1.8.98.2 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19000754&form=6&db=m The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth. causal interaction,ongoing research,unassigned 4,1,0 1.8.98.2 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19057013&form=6&db=m Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies. causal interaction,unassigned 4,0 1.8.98.2 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21487000&form=6&db=m Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling. therapeutic application,unassigned 1,0 1.8.98.2 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21595034&form=6&db=m Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells. diagnostic usage,ongoing research,unassigned 3,2,0 1.8.98.2 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21943684&form=6&db=m Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,2,3 1.8.98.2 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22934964&form=6&db=m Sulfiredoxin redox-sensitive interaction with S100A4 and non-muscle myosin IIA regulates cancer cell motility. ongoing research,therapeutic application,unassigned 1,1,0 1.8.98.2 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24503444&form=6&db=m Tumor promoter-induced sulfiredoxin is required for mouse skin tumorigenesis. causal interaction,unassigned 2,0 1.8.98.2 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26721593&form=6&db=m Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damage. ongoing research,therapeutic application,unassigned 1,1,0 1.8.98.2 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27825965&form=6&db=m Effective killing of cancer cells and regression of tumor growth by K27 targeting sulfiredoxin. unassigned - 1.8.98.2 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28274319&form=6&db=m [Highly expressed sulfiredoxin and ?-catenin are associated with malignancy of cervical squamous cell carcinoma]. diagnostic usage,ongoing research,therapeutic application,unassigned 4,4,1,0 1.8.98.2 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28351308&form=6&db=m Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition. causal interaction,unassigned 3,0 1.8.98.2 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28448437&form=6&db=m Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/?-Catenin Signaling Pathway. therapeutic application,unassigned 1,0 1.8.98.2 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29190947&form=6&db=m Thioredoxin system-mediated regulation of mutant Kras associated pancreatic neoplasia and cancer. causal interaction,unassigned 3,0 1.8.98.2 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29441509&form=6&db=m NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas. causal interaction,unassigned 1,0 1.8.98.2 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30177848&form=6&db=m Chemical proteomics reveals new targets of cysteine sulfinic acid reductase. unassigned - 1.8.98.2 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31394427&form=6&db=m Elucidation of the inhibition mechanism of sulfiredoxin using molecular modeling and development of its inhibitors. therapeutic application,unassigned 2,0 1.8.98.2 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32411320&form=6&db=m Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,4 1.8.98.2 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32746503&form=6&db=m SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,4 1.8.98.2 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25620665&form=6&db=m Sulfiredoxin-1 protects primary cultured astrocytes from ischemia-induced damage. causal interaction,therapeutic application,unassigned 3,4,0 1.8.98.2 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27821734&form=6&db=m Role of sulfiredoxin as a peroxiredoxin-2 denitrosylase in human iPSC-derived dopaminergic neurons. causal interaction,ongoing research,therapeutic application,unassigned 4,1,4,0 1.8.98.2 Pancreatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24189098&form=6&db=m Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma. diagnostic usage,ongoing research,unassigned 3,4,0 1.8.98.2 Pancreatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34140464&form=6&db=m Sulfiredoxin-1 attenuates injury and inflammation in acute pancreatitis through the ROS/ER stress/Cathepsin B axis. causal interaction,unassigned 4,0 1.8.98.2 Periodontal Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30044495&form=6&db=m Comparative estimation of sulfiredoxin levels between chronic periodontitis and healthy patients - A case-control study. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,3,0 1.8.98.2 Periodontitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30044495&form=6&db=m Comparative estimation of sulfiredoxin levels between chronic periodontitis and healthy patients - A case-control study. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,3,0 1.8.98.2 Prostatic Intraepithelial Neoplasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32411320&form=6&db=m Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,4 1.8.98.2 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26637857&form=6&db=m Increased Peroxiredoxin 6 Expression Predicts Biochemical Recurrence in Prostate Cancer Patients After Radical Prostatectomy. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,1 1.8.98.2 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32411320&form=6&db=m Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,4 1.8.98.2 Pulmonary Disease, Chronic Obstructive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26408075&form=6&db=m The aryl hydrocarbon receptor suppresses cigarette-smoke-induced oxidative stress in association with dioxin response element (DRE)-independent regulation of sulfiredoxin 1. causal interaction,unassigned 2,0 1.8.98.2 Skin Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24503444&form=6&db=m Tumor promoter-induced sulfiredoxin is required for mouse skin tumorigenesis. causal interaction,unassigned 2,0 1.8.98.2 Stomach Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30863778&form=6&db=m Increased Sulfiredoxin Expression in Gastric Cancer Cells May Be a Molecular Target of the Anticancer Component Diallyl Trisulfide. causal interaction,unassigned 4,0 1.8.98.2 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25620665&form=6&db=m Sulfiredoxin-1 protects primary cultured astrocytes from ischemia-induced damage. causal interaction,therapeutic application,unassigned 3,4,0 1.8.98.2 Uterine Cervical Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28448437&form=6&db=m Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/?-Catenin Signaling Pathway. therapeutic application,unassigned 1,0